港股異動丨中國心連心化肥(1866.HK)高開逾4% 預計一季度淨利同比增長不低於200%
格隆匯4月13日丨中國心連心化肥(1866.HK)高開逾4%,報3.6港元,總市值42億港元。中國心連心化肥公吿,預計截至2021年3月31日止三個月,集團淨利潤與去年同期相比增長不低於200%。疫情好轉,經濟復甦、能源價格回穩,集團主要產品尿素、三聚氰胺及二甲醚平均售價上漲。九江基地於2021年2月初投產後,產能進一步釋放,藉助技術優勢、成優勢及產品質量優勢,快速提升了集團的競爭力。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.